Travere Therapeutics Inc (NASDAQ:TVTX)

21.71
Delayed Data
As of 3:59pm ET
 -0.82 / -3.64%
Today’s Change
17.97
Today|||52-Week Range
30.35
+3.23%
Year-to-Date

Today’s Trading

Previous close22.53
Today’s open22.33
Day’s range21.68 - 22.54
Volume24,131
Average volume (3 months)886,406
Market cap$1.4B
Data as of 3:59pm ET, 02/03/2023

Growth & Valuation

Earnings growth (last year)+15.55%
Earnings growth (this year)-46.74%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+14.71%
P/E ratioNM
Price/Sales8.16
Price/Book4.48

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...-0.21-1.72%
RCUSArcus Biosciences In...-0.66-3.12%
----
AUPHAurinia Pharmaceutic...-0.25-2.74%
Data as of 3:59pm ET, 02/03/2023

Financials

Next reporting dateFebruary 28, 2023
EPS forecast (this quarter)-$1.07
Annual revenue (last year)$227.5M
Annual profit (last year)-$180.1M
Net profit margin-79.16%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
San Diego, California

Forecasts